About Twist Bioscience
Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.
Headquarters
Twist Bioscience, San Francisco
Founded
2013-01-01
Industry
Biotechnology, Chemical, Health Care, Life Science
Last Funding Type
Post Ipo Equity
Valuation
0.4
Total Funding
$553.11 million dollars
IPO Status
Public
Financial
Twist Bioscience is advancing synthetic DNA solutions through seamless nucleic acid assembly, as described in 'Methods for seamless nucleic acid assembly.' They are also innovating in oligonucleotide synthesis with tethered nucleotides, enhancing enzymatic polynucleotide synthesis. Their research includes variant nucleic acid libraries, such as those for SIRPα antibodies, and parallel substrates for biomolecule processing, which improve multiplexing capabilities. These efforts highlight Twist Bioscience's focus on efficient DNA synthesis, variant library creation, and advanced biomolecule processing.
Funding Rounds
10
Number of Lead Investors
6
Total Funding Amount
$553.11 million dollars
Number of Investors
28